Last update :
28/04/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Cardiotonic   Dopamine hydrochloride  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Abbodop Denmark, Finland, Sweden
Cardiopal Colombia
Dopadic Iran
Dopadren Turkey
Dopamin Austria, Germany, Saudi Arabia, Switzerland
Dopamina Argentina, Chile, Colombia, Ecuador, Italy, Mexico, Peru, Spain, Venezuela
Dopamine Canada, France, Luxembourg, Morocco, Netherlands, United States of America
Dopaminum Poland
Dopmin Denmark, Finland, Malaysia, Turkey
Dynatra Belgium, Luxembourg, Netherlands
Giludop Denmark, Greece, Sweden
Intropin Egypt
Miocina Mexico
Myofast Colombia
Myotil Texte introuvable (616, )
Paldopa Peru
Revivan Mexico
Zetarina Mexico
Stability of mixtures   Injection   Stability of mixtures : Dopamine hydrochloride     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Cefpirome sulfate 50 mg/ml
23°C
8 Hour
Protect from light 280
Level of evidence B+
Glass NaCl 0,9% or Glucose 5% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Bretylium tosilate 10 mg/ml
25°C
48 Hour
Light 705
Glass NaCl 0,9% or Glucose 5% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Bretylium tosilate 10 mg/ml
40°C
48 Hour
Protect from light 705
Glass NaCl 0,9% or Glucose 5% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Bretylium tosilate 10 mg/ml
4°C
7 Day
Protect from light 705
Glass Glucose 5% 1,6 mg/ml
Injection   Dopamine hydrochloride   
Injection   Labetalol hydrochloride 1 mg/ml
20°C-25°C
4 Hour
Light 199
Level of evidence A
Glass Glucose 5% 5 mg/ml
Injection   Dopamine hydrochloride   
Injection   Norepinephrine bitartrate 0,06 mg/ml
22°C
24 Hour
3381
Glass Glucose 5% 3,1 mg/ml
Injection   Dopamine hydrochloride   
Injection   Milrinone lactate 0,2 mg/ml
22°C-23°C
4 Hour
Light 813
Level of evidence A
Glass Glucose 5% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Heparin sodium 20 UI/ml
23°C-25°C
24 Hour
Light 738
Joker
Glass Glucose 5% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Lidocaine hydrochloride 3,26 mg/ml
23°C-25°C
24 Hour
Light 738
Joker
Glass Glucose 5% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Cefalotin sodium 4 mg/ml
23°C-25°C
24 Hour
Light 738
Joker
Glass Glucose 5% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Oxacillin sodium 2 mg/ml
23°C-25°C
24 Hour
Light 738
Joker
Glass Glucose 5% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Gentamicin sulfate 0,32 mg/ml
23°C-25°C
24 Hour
Light 738
Joker
Glass Ringer’s lactate solution 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Cefpirome sulfate 50 mg/ml
23°C
8 Hour
Protect from light 280
Level of evidence B+
Glass NaCl 0,45% Glucose 2,5% 0,6 >> 40 mg/ml
Injection   Dopamine hydrochloride   
Injection   Treprostinil 0,004 >>0,076 mg/ml
25°C
4 Hour
Not specified 4407
Level of evidence A+
Glass NaCl 0,45% Glucose 2,5% 0,6 mg/ml
Injection   Dopamine hydrochloride   
Injection   Treprostinil 0,5 mg/ml
25°C
4 Hour
Not specified 4407
Level of evidence A+
Glass Sodium chloride 0,45% 0,8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Cefpirome sulfate 50 mg/ml
23°C
8 Hour
Protect from light 280
Level of evidence B+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.1 & 1.6 mg/ml
Injection   Dopamine hydrochloride   
Injection   Tirofiban 25 µg/ml
25°C
4 Hour
Light 1420
Level of evidence C+
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,4 & 3,2 mg/ml
Injection   Dopamine hydrochloride   
Injection   Ranitidine hydrochloride 0,05 & 2 mg/ml
?
48 Hour
Not specified 210
Level of evidence B
Polyvinyl chloride Glucose 5% 3,2 mg/ml
Injection   Dopamine hydrochloride   
Injection   Flumazenil 0,02 mg/ml
23°C
12 Hour
Light 187
Level of evidence A
Polyethylene Glucose 5% 5 mg/ml
Injection   Dopamine hydrochloride   
Injection   Norepinephrine bitartrate 0,06 mg/ml
22°C
24 Hour
3381
Polypropylene NaCl 0,9% or Glucose 5% 8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Dobutamine hydrochloride 8 mg/ml
22-25°C
24 Hour
Protect from light 1506
Level of evidence B+
Polypropylene NaCl 0,9% or Glucose 5% 8 mg/ml
Injection   Dopamine hydrochloride   
Injection   Methadone hydrochloride 0.2 mg/ml
22-25°C
24 Hour
Protect from light 1506
Level of evidence B+
Not specified Sodium chloride 0,9% 3,6 mg/ml
Injection   Dopamine hydrochloride   
Injection   Daptomycin 18,2 mg/ml
22°C-28°C
2 Hour
Not specified 1937
Level of evidence C+
  Mentions Légales